Clinical presentation of peritoneal mesothelioma

被引:78
作者
Acherman, YI
Welch, LS
Bromley, CM
Sugarbaker, PH
机构
[1] Washington Hosp Ctr, Washington Canc Inst, Washington, DC 20010 USA
[2] Washington Hosp Ctr, Dept Occupat & Environm Med, Washington, DC USA
[3] Biostat Solut LLC, Damascus, Syria
关键词
ascites; cytoreductive surgery; intraperitoneal chemotherapy; peritoneal mesothelioma; signs; symptoms;
D O I
10.1177/030089160308900307
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To describe the clinical presentation of peritoneal mesothelioma and its impact on survival. Methods: Data was collected from 51 patients with peritoneal mesothelioma treated at the Washington Cancer Institute. The demographic, clinical and pathologic information were analyzed. Results: Pain was the most common symptom (recorded in 33% of patients); increased abdominal girth occurred in 31%, increased abdominal girth and pain in 5%, and a new onset hernia in 12%. In an additional 14% of patients, a variety of other clinical findings led to the diagnosis. There was a statistically significant difference in survival by gender, weight loss and volume of disease. Conclusions: Pain was the most common initial presenting symptom, with increased abdominal girth as a second. A more favorable prognosis occurred in women with a small disease volume.
引用
收藏
页码:269 / 273
页数:5
相关论文
共 24 条
[1]  
ALCORN KW, 2000, SURG ROUNDS, V23, P411
[2]  
ANTMAN KH, 1981, SEMIN ONCOL, V8, P313
[3]  
ASENSIO JA, 1990, ARCH SURG-CHICAGO, V125, P1477
[4]   Pathology of malignant mesothelioma [J].
Attanoos, RL ;
Gibbs, AR .
HISTOPATHOLOGY, 1997, 30 (05) :403-418
[5]   Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity [J].
Bocchetta, M ;
Di Resta, I ;
Powers, A ;
Fresco, R ;
Tosolini, A ;
Testa, JR ;
Pass, HI ;
Rizzo, P ;
Carbone, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (18) :10214-10219
[6]  
ELMES PC, 1976, Q J MED, V45, P427
[7]  
GILKS B, 1988, CANCER, V61, P2019, DOI 10.1002/1097-0142(19880515)61:10<2019::AID-CNCR2820611015>3.0.CO
[8]  
2-K
[9]   Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B [J].
Herndon, JE ;
Green, MR ;
Chahinian, AP ;
Corson, JM ;
Suzuki, Y ;
Vogelzang, NJ .
CHEST, 1998, 113 (03) :723-731
[10]  
Jacquet P, 1996, J EXP CLIN CANC RES, V15, P49